BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 28367275)

  • 41. Stereotactic radiosurgery with concurrent lapatinib is associated with improved local control for HER2-positive breast cancer brain metastases.
    Parsai S; Miller JA; Juloori A; Chao ST; Kotecha R; Mohammadi AM; Ahluwalia MS; Murphy ES; Barnett GH; Vogelbaum MA; Angelov L; Peereboom DM; Suh JH
    J Neurosurg; 2019 Feb; 132(2):503-511. PubMed ID: 30738402
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Stereotactic Radiosurgery With or Without Whole-Brain Radiotherapy for Brain Metastases: Secondary Analysis of the JROSG 99-1 Randomized Clinical Trial.
    Aoyama H; Tago M; Shirato H;
    JAMA Oncol; 2015 Jul; 1(4):457-64. PubMed ID: 26181254
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Postoperative stereotactic radiosurgery without whole-brain radiation therapy for brain metastases: potential role of preoperative tumor size.
    Hartford AC; Paravati AJ; Spire WJ; Li Z; Jarvis LA; Fadul CE; Rhodes CH; Erkmen K; Friedman J; Gladstone DJ; Hug EB; Roberts DW; Simmons NE
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):650-5. PubMed ID: 22795806
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The impact of whole-brain radiation therapy on the long-term control and morbidity of patients surviving more than one year after gamma knife radiosurgery for brain metastases.
    Varlotto JM; Flickinger JC; Niranjan A; Bhatnagar A; Kondziolka D; Lunsford LD
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1125-32. PubMed ID: 15990018
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment of brain metastases from gastrointestinal primaries: Comparing whole-brain radiotherapy and stereotactic radiosurgery in terms of survival.
    Dincer S; Gurbuz D
    North Clin Istanb; 2022; 9(1):47-56. PubMed ID: 35340309
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison between stereotactic radiosurgery and whole-brain radiotherapy for 10-20 brain metastases from non-small cell lung cancer.
    Mizuno T; Takada K; Hasegawa T; Yoshida T; Murotani K; Kobayashi H; Sakurai T; Yamashita Y; Akazawa N; Kojima E
    Mol Clin Oncol; 2019 May; 10(5):560-566. PubMed ID: 30967951
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Novel risk stratification score for predicting early distant brain failure and salvage whole-brain radiotherapy after stereotactic radiosurgery for brain metastases.
    Press RH; Prabhu RS; Nickleach DC; Liu Y; Shu HK; Kandula S; Patel KR; Curran WJ; Crocker I
    Cancer; 2015 Nov; 121(21):3836-43. PubMed ID: 26242475
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prognostic factors for survival in patients treated with stereotactic radiosurgery for recurrent brain metastases after prior whole brain radiotherapy.
    Caballero JA; Sneed PK; Lamborn KR; Ma L; Denduluri S; Nakamura JL; Barani IJ; McDermott MW
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):303-9. PubMed ID: 22079723
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The strategy of repeat stereotactic radiosurgery without whole brain radiation treatment for new brain metastases: Outcomes and implications for follow-up monitoring.
    Shen CJ; Rigamonti D; Redmond KJ; Kummerlowe MN; Lim M; Kleinberg LR
    Pract Radiat Oncol; 2016; 6(6):409-416. PubMed ID: 27687187
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Differential impact of whole-brain radiotherapy added to radiosurgery for brain metastases.
    Kong DS; Lee JI; Im YS; Nam DH; Park K; Kim JH
    Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):385-9. PubMed ID: 20097485
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Repeated Courses of Radiosurgery for New Brain Metastases to Defer Whole Brain Radiotherapy: Feasibility and Outcome With Validation of the New Prognostic Metric Brain Metastasis Velocity.
    Fritz C; Borsky K; Stark LS; Tanadini-Lang S; Kroeze SGC; Krayenbühl J; Guckenberger M; Andratschke N
    Front Oncol; 2018; 8():551. PubMed ID: 30524969
    [No Abstract]   [Full Text] [Related]  

  • 52. A meta-analysis evaluating stereotactic radiosurgery, whole-brain radiotherapy, or both for patients presenting with a limited number of brain metastases.
    Tsao M; Xu W; Sahgal A
    Cancer; 2012 May; 118(9):2486-93. PubMed ID: 21887683
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cost-effectiveness of stereotactic radiosurgery versus whole-brain radiation therapy for up to 10 brain metastases.
    Lester-Coll NH; Dosoretz AP; Magnuson WJ; Laurans MS; Chiang VL; Yu JB
    J Neurosurg; 2016 Dec; 125(Suppl 1):18-25. PubMed ID: 27903191
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Whole brain radiotherapy and stereotactic radiosurgery for patients with recursive partitioning analysis I and lesions <5 cm(3): A matched pair analysis.
    Viani GA; Godoi da Silva LB; Viana BS; Rossi BT; Suguikawa E; Zuliani G
    J Cancer Res Ther; 2016; 12(2):770-4. PubMed ID: 27461649
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prospective study of stereotactic radiosurgery without whole brain radiotherapy in patients with four or less brain metastases: incidence of intracranial progression and salvage radiotherapy.
    Chitapanarux I; Goss B; Vongtama R; Frighetto L; De Salles A; Selch M; Duick M; Solberg T; Wallace R; Cabatan-Awang C; Ford J
    J Neurooncol; 2003 Jan; 61(2):143-9. PubMed ID: 12622453
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Stereotactic radiosurgery of the postoperative resection cavity for brain metastases: prospective evaluation of target margin on tumor control.
    Choi CY; Chang SD; Gibbs IC; Adler JR; Harsh GR; Lieberson RE; Soltys SG
    Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):336-42. PubMed ID: 22652105
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Stereotactic radiosurgery for brain metastases from newly diagnosed small cell lung cancer: practice patterns and outcomes.
    Jiang W; Haque W; Verma V; Butler B; Teh BS
    Acta Oncol; 2019 Apr; 58(4):491-498. PubMed ID: 30676131
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical outcomes of stereotactic radiosurgery in the treatment of patients with metastatic brain tumors.
    Elaimy AL; Mackay AR; Lamoreaux WT; Fairbanks RK; Demakas JJ; Cooke BS; Lee CM
    World Neurosurg; 2011; 75(5-6):673-83. PubMed ID: 21704935
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Survival and outcomes in patients with ≥ 25 cumulative brain metastases treated with stereotactic radiosurgery.
    Benjamin CG; Gurewitz J; Kavi A; Bernstein K; Silverman J; Mureb M; Donahue B; Kondziolka D
    J Neurosurg; 2022 Aug; 137(2):571-581. PubMed ID: 34952524
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Whole-brain radiotherapy versus stereotactic radiosurgery for patients in recursive partitioning analysis classes 1 and 2 with 1 to 3 brain metastases.
    Rades D; Pluemer A; Veninga T; Hanssens P; Dunst J; Schild SE
    Cancer; 2007 Nov; 110(10):2285-92. PubMed ID: 17922523
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.